ArticleFrontiers in oncology2022

Sintilimab Combined with Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma in Second-Line Setting-A Multi-Center Observational Study.

Xiaoyan Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.